{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:40:12Z","timestamp":1787838012066,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T00:00:00Z","timestamp":1236988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Care Anal"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10728-009-0113-4","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T19:25:40Z","timestamp":1236972340000},"page":"103-112","source":"Crossref","is-referenced-by-count":12,"title":["Public Perceptions of Ethical Issues Regarding Adult Predictive Genetic Testing"],"prefix":"10.1007","volume":"18","author":[{"given":"Douglas K.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Nisker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,14]]},"reference":[{"issue":"5\u20136","key":"113_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11017-004-2047-z","volume":"25","author":"L Beckman","year":"2004","unstructured":"Beckman, L. (2004). Are genetic self-tests dangerous? Assessing the commercialization of genetic testing in terms of personal autonomy. Theoretical Medicine and Bioethics, 25(5\u20136), 387\u2013398. doi: 10.1007\/s11017-004-2047-z .","journal-title":"Theoretical Medicine and Bioethics"},{"key":"113_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.publhealth.25.101802.123012","volume":"25","author":"PW Brandt-Rauf","year":"2004","unstructured":"Brandt-Rauf, P. W., & Brandt-Rauf, S. I. (2004). Genetic testing in the workplace: Ethical, legal, and social implications. Annual Review of Public Health, 25, 139. doi: 10.1146\/annurev.publhealth.25.101802.123012 .","journal-title":"Annual Review of Public Health"},{"issue":"1","key":"113_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1503\/cmaj.071656","volume":"179","author":"R Bruni","year":"2008","unstructured":"Bruni, R., Laupacis, A., & Martin, D. K. (2008). The value of public engagement in priority setting. Canadian Medical Association Journal, 179(1), 15\u201318. doi: 10.1503\/cmaj.071656 .","journal-title":"Canadian Medical Association Journal"},{"issue":"9","key":"113_CR4","first-page":"1122","volume":"161","author":"T Caulfield","year":"1999","unstructured":"Caulfield, T. (1999). Gene testing in the biotech century: Are physicians ready? Canadian Medical Association Journal, 161(9), 1122\u20131124.","journal-title":"Canadian Medical Association Journal"},{"key":"113_CR5","first-page":"72","volume":"2","author":"TA Caulfield","year":"2001","unstructured":"Caulfield, T. A., Burgess, M. M., & Williams-Jones, B. (2001). Providing genetic testing through the private sector: A view from Canada. ISUMA: Canadian Journal of Policy Research, 2, 72\u201381.","journal-title":"ISUMA: Canadian Journal of Policy Research"},{"key":"113_CR6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1215\/03616878-18-4-881","volume":"18","author":"C Charles","year":"1993","unstructured":"Charles, C., & DeMaio, S. (1993). Lay participation in health care decision making: A conceptual framework. Journal of Health Politics, Policy and Law, 18, 881\u2013904. doi: 10.1215\/03616878-18-4-881 .","journal-title":"Journal of Health Politics, Policy and Law"},{"issue":"6","key":"113_CR7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra012577","volume":"349","author":"EW Clayton","year":"2003","unstructured":"Clayton, E. W. (2003). Ethical, legal, and social implications of genomic medicine. The New England Journal of Medicine, 349(6), 562\u2013569. doi: 10.1056\/NEJMra012577 .","journal-title":"The New England Journal of Medicine"},{"key":"113_CR8","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1001\/jama.1997.03550190072047","volume":"278","author":"PD Cleary","year":"1997","unstructured":"Cleary, P. D., & Edgman-Levitan, S. (1997). Health care quality: Incorporating consumer perspectives. American Medical Association Journal, 278, 1608\u20131612. doi: 10.1001\/jama.278.19.1608 .","journal-title":"American Medical Association Journal"},{"key":"113_CR9","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/bmj.321.7272.1300","volume":"321","author":"N Daniels","year":"2000","unstructured":"Daniels, N. (2000). Accountability for reasonableness. British Medical Journal, 321, 1300\u20131301. doi: 10.1136\/bmj.321.7272.1300 .","journal-title":"British Medical Journal"},{"key":"113_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0738-3991(98)00085-8","volume":"35","author":"K Vries-Kragt de","year":"1998","unstructured":"de Vries-Kragt, K. (1998). The dilemmas of a carrier of BRCA1 gene mutations. Patient Education and Counseling, 35, 75\u201380. doi: 10.1016\/S0738-3991(98)00085-8 .","journal-title":"Patient Education and Counseling"},{"key":"113_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0738-3991(98)00082-2","volume":"35","author":"G Wert de","year":"1998","unstructured":"de Wert, G. (1998). Ethics of predictive DNA-testing for hereditary breast and ovarian cancer. Patient Education and Counseling, 35, 43\u201352. doi: 10.1016\/S0738-3991(98)00082-2 .","journal-title":"Patient Education and Counseling"},{"key":"113_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.c.10005","volume":"119C","author":"RB Dugan","year":"2003","unstructured":"Dugan, R. B., Wiesner, G. L., Juengst, E. T., O\u2019Riordan, M., Matthews, A. L., & Robin, N. H. (2003). Duty to warn at-risk relatives for genetic disease: Genetic counselor\u2019s clinical experience. American Journal of Medical Genetics Part C, 119C, 27\u201334. doi: 10.1002\/ajmg.c.10005 .","journal-title":"American Journal of Medical Genetics Part C"},{"issue":"5","key":"113_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00129804-200109000-00004","volume":"24","author":"E Giarelli","year":"2001","unstructured":"Giarelli, E. (2001). Ethical issues in genetic testing. Journal of Infusion Nursing, 24(5), 301\u2013310. doi: 10.1097\/00129804-200109000-00004 .","journal-title":"Journal of Infusion Nursing"},{"issue":"5","key":"113_CR14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1200\/JCO.1999.17.5.1595","volume":"17","author":"G Goelen","year":"1999","unstructured":"Goelen, G., Rigo, A., Bonduelle, M., & De Gr\u00e8ve, J. (1999). Moral concerns of different types of patients in clinical BRCA1\/2 gene mutation testing. Journal of Clinical Oncology, 17(5), 1595\u20131600.","journal-title":"Journal of Clinical Oncology"},{"key":"113_CR16","first-page":"186","volume":"7","author":"R Greenberg","year":"2008","unstructured":"Greenberg, R., Laupacis, A., Levinson, W., & Martin, D. K. (2008). Priority setting in the Ontario wait time strategy: Evaluating public involvement. BioMed Central Health Services Research, 7, 186.","journal-title":"BioMed Central Health Services Research"},{"issue":"6","key":"113_CR17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2005.00443.x","volume":"67","author":"N Hallowell","year":"2005","unstructured":"Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2005). Communication about genetic testing in families of male BRCA1\/2 carriers and non-carriers: Patterns, priorities and problems. Clinical Genetics, 67(6), 492\u2013502. doi: 10.1111\/j.1399-0004.2005.00443.x .","journal-title":"Clinical Genetics"},{"issue":"2","key":"113_CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jme.29.2.74","volume":"29","author":"N Hallowell","year":"2003","unstructured":"Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., Murday, V., & Watson, M. (2003). Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. Journal of Medical Ethics, 29(2), 74\u201383. doi: 10.1136\/jme.29.2.74 .","journal-title":"Journal of Medical Ethics"},{"issue":"6901","key":"113_CR19","first-page":"436","volume":"307","author":"C Ham","year":"1993","unstructured":"Ham, C. (1993). Rationing in action: Priority Setting in the NHS: Reports from six districts. British Medical Journal, 307(6901), 436.","journal-title":"British Medical Journal"},{"issue":"5","key":"113_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1470-2045(05)70166-2","volume":"6","author":"M Harris","year":"2005","unstructured":"Harris, M., Winship, I., & Spriggs, M. (2005). Controversies and ethical issues in cancer-genetics clinics. The lancet Oncology, 6(5), 301\u2013310. doi: 10.1016\/S1470-2045(05)70166-2 .","journal-title":"The lancet Oncology"},{"key":"113_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0738-3991(98)00083-4","volume":"35","author":"AK Huibers","year":"1998","unstructured":"Huibers, A. K., & van\u2019t Spijker, A. (1998). The autonomy paradox: Predictive genetic testing and autonomy: Three essential problems. Patient Education and Counseling, 35, 53\u201362. doi: 10.1016\/S0738-3991(98)00083-4 .","journal-title":"Patient Education and Counseling"},{"key":"113_CR22","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1136\/bmj.316.7145.1668","volume":"316","author":"J Jordan","year":"1998","unstructured":"Jordan, J., Dowswell, T., Harrison, S., Lilford, R. J., & Mort, M. (1998). Health needs assessment: Whose priorities? Listening to users and the public. British Medical Journal, 316, 1668\u20131670.","journal-title":"British Medical Journal"},{"key":"113_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jme.29.1.16","volume":"29","author":"A Kent","year":"2003","unstructured":"Kent, A. (2003). Consent and confidentiality in genetics: Whose information is it anyway? Journal of Medical Ethics, 29, 16\u201318. doi: 10.1136\/jme.29.1.16 .","journal-title":"Journal of Medical Ethics"},{"issue":"2","key":"113_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0167-7799(01)01879-0","volume":"20","author":"BM Knoppers","year":"2002","unstructured":"Knoppers, B. M. (2002). Genetic information and the family: Are we our brother\u2019s keeper? Trends in Biotechnology, 20(2), 85\u201386. doi: 10.1016\/S0167-7799(01)01879-0 .","journal-title":"Trends in Biotechnology"},{"issue":"1\u20132","key":"113_CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-8510(99)00042-1","volume":"49","author":"J Lenaghan","year":"1999","unstructured":"Lenaghan, J. (1999). Involving the public in rationing decisions. The experience of citizens\u2019 juries. Health Policy (Amsterdam), 49(1\u20132), 45\u201361. doi: 10.1016\/S0168-8510(99)00042-1 .","journal-title":"Health Policy (Amsterdam)"},{"key":"113_CR26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1258\/135581902320432750","volume":"7","author":"DK Martin","year":"2002","unstructured":"Martin, D. K., Abelson, J., & Singer, P. A. (2002). Participation in health care priority setting through the eyes of the participants. Journal of Health Services Research & Policy, 7, 222\u2013229. doi: 10.1258\/135581902320432750 .","journal-title":"Journal of Health Services Research & Policy"},{"issue":"1","key":"113_CR27","first-page":"23","volume":"27","author":"R Mykitiuk","year":"2004","unstructured":"Mykitiuk, R. (2004). Caveat emptor: Direct-to-consumer supply and advertising of genetic testing. Clinical and Investigative Medicine, 27(1), 23\u201332.","journal-title":"Clinical and Investigative Medicine"},{"key":"113_CR28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.healthpol.2005.10.009","volume":"78","author":"J Nisker","year":"2006","unstructured":"Nisker, J., Martin, D. K., Bluhm, R., & Daar, A. S. (2006). Theatre as a public engagement tool for health-policy development. Health Policy (Amsterdam), 78, 258\u2013271. doi: 10.1016\/j.healthpol.2005.10.009 .","journal-title":"Health Policy (Amsterdam)"},{"issue":"2","key":"113_CR29","first-page":"116","volume":"5","author":"DF Ossa","year":"2004","unstructured":"Ossa, D. F., & Towse, A. (2004). Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers? The European Journal of Health Economics, 5(2), 116\u2013121. doi: 10.1007\/s10198-003-0213-2 .","journal-title":"The European Journal of Health Economics"},{"issue":"1","key":"113_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/016224390002500101","volume":"25","author":"G Rowe","year":"2000","unstructured":"Rowe, G., & Frewer, L. J. (2000). Public participation methods: A framework for evaluation. Science, Technology & Human Values, 25(1), 3\u201329.","journal-title":"Science, Technology & Human Values"},{"key":"113_CR31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2307\/977561","volume":"58","author":"C Simrell King","year":"1998","unstructured":"Simrell King, C. (1998). The question of participation: Toward authentic public participation in public administration. Public Administration Review, 58, 317\u2013326. doi: 10.2307\/977561 .","journal-title":"Public Administration Review"},{"key":"113_CR32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11096-005-8512-6","volume":"27","author":"JM Traulsen","year":"2005","unstructured":"Traulsen, J. M., & Almarsdottir, B. (2005). Pharmaceutical policy and the lay public. Pharmacy World & Science, 27, 273\u2013277. doi: 10.1007\/s11096-005-8512-6 .","journal-title":"Pharmacy World & Science"},{"key":"113_CR33","unstructured":"Wellcome Trust. (2004). Public engagement: Sciart. www.wellcome.ac.uk\/Funding\/Public-engagement\/Past-funding\/WTD038569.htm ."},{"issue":"4","key":"113_CR34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1748-720X.1997.tb01406.x","volume":"25","author":"BS Wilfond","year":"1997","unstructured":"Wilfond, B. S., Rothenberg, K. H., Thomson, E. J., & Lerman, C. (1997). Cancer genetic susceptibility testing: Ethical and policy implications for future research and clinical practice. The Journal of Law, Medicine & Ethics, 25(4), 243\u2013251. doi: 10.1111\/j.1748-720X.1997.tb01406.x .","journal-title":"The Journal of Law, Medicine & Ethics"}],"container-title":["Health Care Analysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10728-009-0113-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10728-009-0113-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10728-009-0113-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:47:52Z","timestamp":1559256472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10728-009-0113-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,14]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1007\/s10728-009-0113-4","relation":{},"ISSN":["1065-3058","1573-3394"],"issn-type":[{"value":"1065-3058","type":"print"},{"value":"1573-3394","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,14]]}}}